Marksans Pharma informs about conference call

31 Oct 2025 Evaluate
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that the Company has scheduled a conference call for analysts and investors on Friday, November 14, 2025 at 05:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025. The details and schedule with respect to the conference call are enclosed. The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html.

The above information is a part of company’s filings submitted to BSE. 

Marksans Pharma Share Price

172.25 -0.20 (-0.12%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×